ETFsXtrackers Europe Net Zero Pathway Paris Aligned UCITS ETF 1C
Xtrackers
Xtrackers Europe Net Zero Pathway Paris Aligned UCITS ETF 1C
XEPA XETRAAccumulatingIreland
Last close · EUR
45.73EUR
-0.13% · -€0.06
Published closes: 29 Oct 2026 - 30 Oct 2026
30 Oct 2026, close
XEPABase
- Fund charges
- Not publishedFee basis unverified
- Fund size
- Not published
- Return 1Y
- +13.2%
- Sharpe 3Y
- 0.81
- Volatility 1Y
- 13.1%annualised
- Holdings
- 292Fund holdings
Performance
Compare
- XEPA+13.2%
- Price, EUR
Returns
| Returns | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|
| XEPA | +2.8% | +0.8% | +9.1% | +10.0% | +13.2% | +51.1% | - |
| MSCI World | +0.4% | +4.9% | +10.8% | +16.0% | +15.9% | +75.5% | +71.2% |
| Gap to MSCI World | +2.3% | -4.0% | -1.7% | -6.0% | -2.7% | -24.4% | - |
Risk and return
Sharpe ratio · 3Y
0.81
Below MSCI World · 1.24- Return p.a.
- +13.3%
- Volatility
- 13.0%
- Max loss
- -17.2%Apr 2025
Sharpe vs indices
MSCI World
1.24
S&P 500
1.21
STOXX Europe 600
1.04
MSCI Emerging Markets IMI
0.93
XEPA
0.81
CAC 40
0.37
Method
Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.
Top holdings
- Top 10
- 23.8%
- Holdings
- 292
- As of
- 1ASML HOLDINGNL00102732155.54%
- 2ROCHE PS PAR AGCH14990599832.84%
- 3HSBC HOLDINGS PLCGB00054052862.49%
- 4NOVARTIS AGCH00120052672.42%
- 5ASTRAZENECA PLCGB00098952922.31%
- 6NESTLE SACH00388633502.15%
- 7SAPDE00071646001.81%
- 8SIEMENS N AGDE00072361011.67%
- 9ALLIANZDE00084040051.37%
- 10BANCO SANTANDERES0113900J371.22%
Countries
Classified 99.9%
GB
CH
DE
France10.7%
NL
SE
DK
IT
ES
BE
FI
NO
- Largest
- 16.8%United Kingdom
- Top 3
- 45.9%
- Effective number
- 9.51 / HHI
Market cap
Weight vs holdings
23.8%of the fund sits in the top 10 holdings
23.8%28.7%41.4%
WeightHoldings
4015092
- Holdings 1-10
- Holdings 11-50
- Holdings 51-200
- Holdings 201+
Size split
Not published
Compare ETFs in Copio.
Factual research, without a suitability score or investment recommendation. Past relationships can change.
